This story has been updated from a previous version.

NEW YORK, May 29 - Sequenom has agreed to acquire Gemini Genomics in a stock-for-stock deal valued at $238 million, the companies said Tuesday.   

The merger will leverage Sequenom's capabilities in large-scale genetic analysis with Gemini's databases of clinical and phenotypical information, the companies said.  

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.